ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $558,000 | -9.4% | 381,953 | -12.0% | 0.00% | -100.0% |
Q4 2016 | $616,000 | -21.7% | 434,153 | -3.4% | 0.00% | 0.0% |
Q3 2016 | $787,000 | +2.3% | 449,653 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $769,000 | -13.2% | 449,653 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $886,000 | +3.7% | 449,653 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $854,000 | -0.6% | 449,653 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $859,000 | -58.9% | 449,653 | -0.1% | 0.00% | -50.0% |
Q2 2015 | $2,089,000 | +6.2% | 450,133 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $1,967,000 | +21.3% | 450,133 | -3.7% | 0.00% | +100.0% |
Q4 2014 | $1,622,000 | -17.2% | 467,433 | 0.0% | 0.00% | -50.0% |
Q3 2014 | $1,959,000 | -28.5% | 467,433 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $2,739,000 | -7.0% | 467,433 | 0.0% | 0.00% | -33.3% |
Q1 2014 | $2,945,000 | +21.7% | 467,433 | +13.0% | 0.00% | +50.0% |
Q4 2013 | $2,420,000 | -0.6% | 413,695 | -10.5% | 0.00% | 0.0% |
Q3 2013 | $2,435,000 | -31.9% | 462,085 | -0.6% | 0.00% | -50.0% |
Q2 2013 | $3,578,000 | – | 464,652 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 1,281,400 | $6,753,000 | 3.37% |
Perceptive Advisors | 5,116,200 | $26,962,000 | 1.11% |
SAMLYN CAPITAL, LLC | 2,266,565 | $11,945,000 | 0.33% |
Tradeworx Inc. | 132,839 | $700,000 | 0.32% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,216,579 | $6,411,000 | 0.30% |
Lyons Wealth Management, LLC. | 56,775 | $299,000 | 0.27% |
DIALECTIC CAPITAL MANAGEMENT, LP | 125,000 | $659,000 | 0.15% |
Schonfeld Group Holdings LLC | 11,400 | $60,000 | 0.12% |
DIALECTIC CAPITAL MANAGEMENT, LP | 70,000 | $369,000 | 0.08% |
ELLINGTON MANAGEMENT GROUP LLC | 72,000 | $379,000 | 0.07% |